|
CRT has to varying degrees been instrumental in the formation and development of the following companies:
Antisoma Research PLC
Antisoma is a biotechnology company specialising in the development of novel anti-cancer drugs. [website]
Chroma Therapeutics Limited
Chroma Therapeutics was founded to exploit the potential
of chromatin biology for cancer drug discovery. The company
is focused on the identification of novel anti-cancer agents
that combine the efficacy of cytotoxics with the tumour cell
selectivity of modern targeted therapeutics. [website]
Crusade Laboratories Limited
Crusade Laboratories is focused on the development of
herpes simplex virus (HSV) for the treatment of cancer. [website]
Cyclacel Limited
Cyclacel is a biopharmaceutical company that designs and
develops small molecule drugs that act on key cell cycle regulators
to stop uncontrolled cell division in cancer and other diseases
involving abnormal cell proliferation. [website]
Epistem Limited
Epistem is an independent contract research company, providing
pre-clinical research services to the Biotechnology and Pharmaceutical
industries. [website]
Hybrid Systems Limited
Hybrid Systems is exploiting the interface between polymer chemistry and biology to generate new products and tools for applications in areas as diverse as gene therapy, vaccination, agriculture and bioremediation. [website]
InferMed Limited
InferMed is a software and services provider that offers a range of software solutions for collecting and managing data that is designed for improving patient outcomes and delivering drugs and therapies to market more efficiently. [website]
KuDOS Pharmaceuticals Limited
An organisation that is focussed on the discovery and development of drugs based upon the science of DNA damage sensing, signalling and repair to address unmet medical needs in cancer treatment. [website]
PETRRA Limited
PETRRA is a start-up company that was created to make and
develop a new type of PET (Positron Emission Tomography) scanner.
The PETRRA scanner differes from currently available technology
in the nature of its detectors and signal processing and offers
significant technological and cost advantages. [website]
Phogen Limited
Phogen is a biotechnology company engaged in development and commercialization of drug delivery technologies.
PIramed Limited
PIramed's principal target focus is the superfamily of lipid kinases, exemplified by phosphatidylinositol 3-kinase (PI3-kinase), for the treatment of cancer and other diseases. [website]
Proacta Therapeutics Limited
Proacta is an oncology drug discovery company targeting tumour hypoxia, a condition that exists in the majority of solid tumours. [website]
Spear Therapeutics
Spear is a small molecule drug design company, with proprietary expertise in drug-activating mechanisms, focused on the treatment of cancers.
Spirogen Limited
Spirogen is a company pioneering the discovery and development of a unique class of low molecular weight sequence-specific DNA-interactive drugs designed to treat gene-mediated diseases. [website] |
